152 related articles for article (PubMed ID: 9417748)
21. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
[TBL] [Abstract][Full Text] [Related]
22. First clinical experience with low molecular weight heparin LU 47311 (reviparin) for prevention of restenosis after percutaneous transluminal coronary angioplasty.
Schmid KM; Preisack M; Voelker W; Sujatta M; Karsch KR
Semin Thromb Hemost; 1993; 19 Suppl 1():155-9. PubMed ID: 8395719
[TBL] [Abstract][Full Text] [Related]
23. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
[TBL] [Abstract][Full Text] [Related]
24. Low molecular weight heparin in prevention of restenosis after PTCA.
Preisack MB; Karsch KR
Thromb Res; 1996; 81(2 Suppl):S53-9. PubMed ID: 8822128
[TBL] [Abstract][Full Text] [Related]
25. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.
Circulation; 1997 Sep; 96(5):1445-53. PubMed ID: 9315530
[TBL] [Abstract][Full Text] [Related]
26. Safety of low dose heparin in elective coronary angioplasty.
Koch KT; Piek JJ; de Winter RJ; David GK; Mulder K; Tijssen JG; Lie KI
Heart; 1997 Jun; 77(6):517-22. PubMed ID: 9227294
[TBL] [Abstract][Full Text] [Related]
27. Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation.
Yusuf S; Mehta SR; Xie C; Ahmed RJ; Xavier D; Pais P; Zhu J; Liu L;
JAMA; 2005 Jan; 293(4):427-35. PubMed ID: 15671427
[TBL] [Abstract][Full Text] [Related]
28. Low-molecular-weight heparin in arterial reconstructive surgery: a double-blind, randomized dose-finding trial.
Kujath P; Eckmann C; Misselwitz F
Clin Appl Thromb Hemost; 2002 Oct; 8(4):337-45. PubMed ID: 12516683
[TBL] [Abstract][Full Text] [Related]
29. Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
Grip L; Blombäck M; Egberg N; Olsson A; Svane B; Velander M
Eur Heart J; 1997 Mar; 18(3):443-9. PubMed ID: 9076381
[TBL] [Abstract][Full Text] [Related]
30. Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study.
Cairns JA; Gill J; Morton B; Roberts R; Gent M; Hirsh J; Holder D; Finnie K; Marquis JF; Naqvi S; Cohen E
Circulation; 1996 Oct; 94(7):1553-60. PubMed ID: 8840843
[TBL] [Abstract][Full Text] [Related]
31. Adjunctive intracoronary infusion of antithrombin III during percutaneous transluminal coronary angioplasty. Results of a prospective, randomized trial.
Schächinger V; Allert M; Kasper W; Just H; Vach W; Zeiher AM
Circulation; 1994 Nov; 90(5):2258-66. PubMed ID: 7955182
[TBL] [Abstract][Full Text] [Related]
32. Prevention of coronary arterial renarrowing by continuous 3-day infusion of tissue plasminogen activator after successful percutaneous transluminal coronary angioplasty: a randomized, double-blind, placebo-controlled study.
Kanamasa K; Ogawa I; Hayashi T; Nakabayashi T; Otani N; Ishikawa K
Angiology; 2000 May; 51(5):367-75. PubMed ID: 10826853
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of low-molecular-weight heparin delivery with the Dispatch catheter following balloon angioplasty in the rabbit iliac artery.
Baumbach A; Oberhoff M; Bohnet A; Miljak T; Herdeg C; Horch B; Blessing E; Kunert W; Haase KK; Karsch KR
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):303-7. PubMed ID: 9213029
[TBL] [Abstract][Full Text] [Related]
34. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty.
Desmet W; Vrolix M; De Scheerder I; Van Lierde J; Willems JL; Piessens J
Circulation; 1994 Jan; 89(1):385-92. PubMed ID: 8281674
[TBL] [Abstract][Full Text] [Related]
36. Heparin infusion prior to stenting (HIPS) trial: final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia.
Wilensky RL; Tanguay JF; Ito S; Bartorelli AL; Moses J; Williams DO; Bailey SR; Martin J; Bucher TA; Gallant P; Greenberg A; Popma JJ; Weissman NJ; Mintz GS; Kaplan AV; Leon MB
Am Heart J; 2000 Jun; 139(6):1061-70. PubMed ID: 10827388
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of coronary restenosis by antithrombin III in atherosclerotic swine.
Ali MN; Mazur W; Kleiman NS; Rodgers GP; Abukhalil JM; French BA; Raizner AE
Coron Artery Dis; 1996 Nov; 7(11):851-61. PubMed ID: 8993944
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial.
Yokoi H; Daida H; Kuwabara Y; Nishikawa H; Takatsu F; Tomihara H; Nakata Y; Kutsumi Y; Ohshima S; Nishiyama S; Seki A; Kato K; Nishimura S; Kanoh T; Yamaguchi H
J Am Coll Cardiol; 1997 Oct; 30(4):855-62. PubMed ID: 9316509
[TBL] [Abstract][Full Text] [Related]
39. Local and systemic delivery of low molecular weight heparin stimulates the reendothelialization after balloon angioplasty.
Oberhoff M; Novak S; Herdeg C; Baumbach A; Kranzhöfer A; Bohnet A; Horch B; Hanke H; Haase KK; Karsch KR
Cardiovasc Res; 1998 Jun; 38(3):751-62. PubMed ID: 9747444
[TBL] [Abstract][Full Text] [Related]
40. Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.
Bertrand ME; McFadden EP; Fruchart JC; Van Belle E; Commeau P; Grollier G; Bassand JP; Machecourt J; Cassagnes J; Mossard JM; Vacheron A; Castaigne A; Danchin N; Lablanche JM
J Am Coll Cardiol; 1997 Oct; 30(4):863-9. PubMed ID: 9316510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
